Palantir’s Growth Momentum Faces Political Storms—Is the Valuation Justified?
Explore Palantir’s record growth versus looming political risks—NHS contracts, EU AI scrutiny, and a 110‑fold P/E. Is the stock over‑valued or a hidden gem? Read more.
4 minutes to read



